INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE)

Historical Holders from Q1 2016 to Q4 2025

Type / Class
Equity / BIOTECHNOLOGY
Symbol
PBE
Price per share
$82.15
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
978,161
Total reported value
$68,443,763
% of total 13F portfolios
0%
Share change
-297,422
Value change
-$20,741,914
Avg buy value change
+0%
Avg sell value change
-0%
Number of holders
98
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
As of 30 Sep 2025, INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE) has 98 institutional shareholders filing 13F forms. They hold 978,161 shares. .

Institutional Holders of INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q4 11,575 $959,630 +$245,018 8,215.46% 4
2025 Q3 978,161 $68,443,763 -$20,741,914 6,987% 98
2025 Q2 1,279,366 $82,042,244 -$2,861,254 6,410% 95
2025 Q1 1,323,152 $83,927,905 -$175,978 6,344% 95
2024 Q4 1,323,012 $88,022,480 +$667,429 6,652.86% 97
2024 Q3 1,322,938 $92,410,456 -$7,574,959 6,982% 103
2024 Q2 1,431,709 $92,798,649 +$14,972,137 6,481.37% 101
2024 Q1 1,201,145 $77,685,792 -$12,767,012 6,471.56% 101
2023 Q4 1,397,613 $92,022,414 +$6,991,090 6,584% 96
2023 Q3 1,295,402 $73,895,313 -$254,994 5,703.68% 96
2023 Q2 1,302,175 $79,837,312 +$58,833 6,128.67% 97
2023 Q1 1,291,721 $81,080,858 +$5,249,953 6,276.84% 101
2022 Q4 1,214,949 $77,291,238 +$6,566,835 6,349.7% 104
2022 Q3 1,105,155 $65,143,145 -$3,371,819 5,894.23% 86
2022 Q2 1,091,048 $63,008,282 +$10,723,748 5,774% 85
2022 Q1 923,615 $57,254,786 -$10,438,186 6,201.41% 87
2021 Q4 1,082,332 $77,074,486 +$6,750,041 7,121.13% 100
2021 Q3 974,984 $73,002,339 +$4,465,636 7,484.91% 96
2021 Q2 909,559 $70,309,819 +$3,371,337 7,733.08% 93
2021 Q1 866,188 $63,984,793 +$102,795 7,382% 87
2020 Q4 863,913 $60,639,901 -$3,846,629 7,013.07% 80
2020 Q3 925,697 $52,523,167 +$730,115 5,662% 71
2020 Q2 910,704 $53,116,808 -$2,922,278 5,827.48% 75
2020 Q1 978,277 $45,696,504 -$4,876,334 4,649.52% 74
2019 Q4 1,103,498 $61,487,674 -$7,764,579 5,585% 76
2019 Q3 1,208,004 $57,187,897 -$1,297,504 4,736.84% 71
2019 Q2 1,236,332 $66,128,491 -$12,699,172 5,351.3% 77
2019 Q1 1,464,486 $80,729,263 -$5,581,751 5,518.4% 77
2018 Q4 1,605,516 $75,745,955 +$176,610 4,707.01% 70
2018 Q3 1,569,010 $93,215,714 +$39,617,813 5,944.96% 70
2018 Q2 938,078 $50,678,083 +$50,325,083 5,471.05% 69
2016 Q2 0 $0 -$90,000 0
2016 Q1 1,603 $90,000 5,614.47% 1